Precigen Competitors and Similar CompaniesClear all

Precigen's competitors and similar companies include Cell Therapies, Mediphage Bioceuticals, Ethris and ProQR Therapeutics.

	Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.	Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.	Mediphage Bioceuticals Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.	Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.	ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date	Founding Date 1998	Founding Date 2003	Founding Date 2016	Founding Date 2009	Founding Date 2012
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations Germantown, US HQ Gent, BE Sioux Center, US	Locations Melbourne, AU HQ	Locations Toronto, CA HQ	Locations Planegg, DE HQ	Locations Leiden, NL HQ Cambridge, US
Employees	Employees 601	Employees 733% decrease	Employees 1023% decrease	Employees 504% decrease	Employees 166
Valuation ($)	Valuation ($) 246.6 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 281.8 m
Financial
Revenue (est.)	Revenue (est.) $9.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €15.9m (FY, 2025)
Net income	Net income ($250.6m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income (€42.2m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 379m	Total funding raised N/A	Total funding raised $ 4.1m	Total funding raised N/A	Total funding raised $ 57.8m